Skip to main content
OpenTrials
Completed

NCT Number: NCT02500628

Heart Rate Variability in Response to Metformin Challenge

Diseases caused by brain energy supply defects can be innate (fibromyalgia secondary to familial mitochondrial disorders) or acquired (tardive dyskinesia or weight gain associated with prolonged antipsychotic use). Patients with these possible mitochondrial disorders will provide a baseline resting heart rate sample, ingest low-dose metformin (500 mg), and then provide an additional sample 2 hours later.

Completed

Looking for future studies?

Notify Me

Key information

About this study

Doctors need to develop tests which inexpensively and reliably evaluates brain metabolism. Current diagnostic tests sample other tissues which often run on different fuels (fats), utilize unproven and often insensitive brain imaging scanners, or sequence thousands to millions of base-pairs of DNA. All of these tests are expensive. None of these tests accurately or completely capture the interactions between the 1000s of proteins involved in brain metabolism.

The investigators suspect that mathematical analysis of the resting heart rate may provide some insight into brain metabolism. The brain controls heart rate in response to changes in blood pressure and blood gases like carbon dioxide and oxygen. Tight control of heart rate is necessary to make sure that the brain has the right mix of fuel and air. Because the brain can't respond instantly to changes in its fuel supply, this system acting as a biological carburetor has a natural oscillatory rhythm that can be monitored just like frequencies on the radio.

The investigators propose to amplify these rhythms by modestly metabolically stressing the brain with metformin, a inhibitor of complex 1 in the mitochondria.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

EITHER chronic neurogenic pain meeting American College of Rheumatology criteria for fibromyalgia or previous/current exposure to antipsychotic medications

Exclusion criteria

  • recent infection,
  • renal failure,
  • pre-existing cardiac disease,
  • chronic obstructive pulmonary disease
  • inability to participate in informed consent,
  • lack of transport to return home from study site,
  • severe fasting intolerance or hypoglycemia,
  • history of stroke-alike episode,
  • uncontrolled migraine or cyclic vomiting,
  • diabetes on insulin or sulfonylurea,
  • non-English speaker,
  • medications with strong effects on baseline heart rate variability

Treatment and study plan

metformin

Drug

500 mg orally after baseline testing of heart rate

Other names: Glucophage

Primary outcomes

  1. Heart Rate Variability (Time Domain)

    Time frame: difference pre/post metformin ingestion (2 hours)

    ratio of the standard deviation of sampled intervals between each heart beat for ten minutes at time 1 (prior to metformin ingestion) over standard deviation of the sampled intervals between each heart beat for ten minutes at time 2 (2 hours post metformin ingestion)

  2. Heart Rate Variability (Frequency Domain)

    Time frame: difference pre/post metformin ingestion (2 hours)

    total power in the frequency domain is estimated for 10 minutes prior to metformin ingestion and then divided by the total power in the frequency domain estimated for 10 minutes 2 hours after metformin ingestion. Ratio is log-transformed.

Secondary outcomes

  1. Number of Patients Reporting Side Effects From the Medication

    Time frame: 2 hours after ingestion

    Patient after testing generated an unprompted list of observed side effects from the medication. Many reported none. Results were scored as the binary presence or absence of side effect

Sponsors and collaborators

Lead sponsor

Woodinville Psychiatric Associates

Other

Registry information

Important dates

Study start
2015
Primary completion
2016
Study completion
2016
First posted
Jul 16, 2015
Registry last updated
Jan 3, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.